Cited 0 times in
한국 여성에서 호르몬 치료 중 진단된 유방암의 임상적 특성
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이병석 | - |
dc.date.accessioned | 2015-04-24T17:42:49Z | - |
dc.date.available | 2015-04-24T17:42:49Z | - |
dc.date.issued | 2009 | - |
dc.identifier.issn | 1226-8704 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/105926 | - |
dc.description.abstract | Objectives: This study was performed to evaluate clinical characteristics of breast cancers diagnosed in Korean women on hormone therapy (HT). Methods: In 95 patients who were diagnosed with primary breast cancer under current HT, information on clinical characteristics, HT, and breast cancer was derived from the medical records. Results: The mean age of menarche, menopause, and cancer diagnosis (±SD) was 15.6±1.6, 48.0±5.0, and 54.1±6.3 years, respectively. Thirty-eight percent of the patients received estrogen therapy and the 62% of the patients received combination therapy. The duration of HT was 41.3±34.9 months (range, 1∼151 months). Of note, 36.8% of the patients (35/95) received HT for <2 years. Forty percent of the patients (38/95) of patients had risk factor(s) for breast cancer. Ninety-three percent of the patients (88/95) underwent surgery as a primary treatment, and breast conservation surgery was performed in 38.6% of the patients (34/88). Ductal cancer was the histologic diagnosis in 94.4 %of the patients (85/90). Seventy-six percent of the patients (62/82) had at least 1 of the following good prognostic factors: stages 0 and I, 63.3% (50/79) tumor size <2 cm, 66.2% (49/74) estrogen receptor-positive tumors, 65.3% (47/72) and tumors without axillary lymph node involvement, 74.0% (57/77). Conclusion: This retrospective study suggests that breast cancer diagnosed in Korean women while taking HT have a favorable prognosis, possibly due to earlier detection and lower biologic aggressiveness. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 172~177 | - |
dc.relation.isPartOf | Journal of Korean Society of Menopause (대한폐경학회지) | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | 한국 여성에서 호르몬 치료 중 진단된 유방암의 임상적 특성 | - |
dc.title.alternative | Clinical Characteristics of Breast Cancers Diagnosed in Korean Women on Hormone Therapy | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Obstetrics & Gynecology (산부인과학) | - |
dc.contributor.googleauthor | 이동윤 | - |
dc.contributor.googleauthor | 윤병구 | - |
dc.contributor.googleauthor | 김미란 | - |
dc.contributor.googleauthor | 정혜원 | - |
dc.contributor.googleauthor | 이병석 | - |
dc.contributor.googleauthor | 강병문 | - |
dc.contributor.googleauthor | 최 훈 | - |
dc.contributor.googleauthor | 박형무 | - |
dc.contributor.googleauthor | 김정구 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A02795 | - |
dc.relation.journalcode | J01546 | - |
dc.subject.keyword | Hormone therapy | - |
dc.subject.keyword | Breast cancer | - |
dc.subject.keyword | Clinical characteristics | - |
dc.subject.keyword | Prognostic factors | - |
dc.contributor.alternativeName | Lee, Byung Seok | - |
dc.contributor.affiliatedAuthor | Lee, Byung Seok | - |
dc.citation.volume | 15 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 172 | - |
dc.citation.endPage | 177 | - |
dc.identifier.bibliographicCitation | Journal of Korean Society of Menopause (대한폐경학회지), Vol.15(3) : 172-177, 2009 | - |
dc.identifier.rimsid | 51445 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.